Ursodeoxycholic acid improves litter and renal biological parameters in liver transplant patients treated with Neoral (cyclosporin A).

被引:0
|
作者
Caroli-Bosc, FX
Montet, JC
Peten, EP
Demuth, N
Demarquay, JF
Delmont, JP
机构
[1] Hop Archet 2, Serv Hepatol, Nice, France
[2] INSERM Hepatol, Marseille, France
关键词
D O I
10.1016/S0016-5085(98)84946-9
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
L0084
引用
收藏
页码:A1219 / A1219
页数:1
相关论文
共 50 条
  • [31] The Nordic multicenter double-blind randomized controlled trial of prophylactic ursodeoxycholic acid in liver transplant patients
    Keiding, S
    Hockerstedt, K
    Bjoro, K
    Bondesen, S
    Hjortrup, A
    Isoniemi, H
    Erichsen, C
    Soderdahl, G
    Ericzon, BG
    TRANSPLANTATION, 1997, 63 (11) : 1591 - 1594
  • [32] Renal function in liver transplant patients treated for recurrent hepatitis C with sofosbuvir and simeprevir
    Basil, Anjali
    Bozorgzadeh, Adel
    Barnard, Graham F.
    HEPATOLOGY, 2014, 60 (06) : 1282A - 1282A
  • [33] SATURABLE BINDING OF CYCLOSPORIN-A TO ERYTHROCYTES - ESTIMATION OF BINDING PARAMETERS IN RENAL-TRANSPLANT PATIENTS AND IMPLICATIONS FOR BIOAVAILABILITY ASSESSMENT
    LEGG, B
    ROWLAND, M
    PHARMACEUTICAL RESEARCH, 1988, 5 (02) : 80 - 85
  • [34] INTERLEUKIN-2 RECEPTOR POSITIVE CELL LEVELS IN CYCLOSPORIN-TREATED VERSUS AZATHIOPRINE-TREATED RENAL-TRANSPLANT PATIENTS
    MOHRING, K
    POMER, S
    DANIEL, U
    RAMBAUSEK, M
    TRANSPLANTATION PROCEEDINGS, 1989, 21 (01) : 1469 - 1469
  • [35] LIVER STIFFNESS DYNAMICS PREDICT SURVIVAL IN PATIENTS WITH PRIMARY BILIARY CHOLANGITIS (PBC) TREATED WITH URSODEOXYCHOLIC ACID (UDCA)
    Rigamonti, Cristina
    De Benedittis, Carla
    Azzolina, Danila
    Costanzo, Martina
    Pirovano, Alice
    Croce, Alessandro
    Fangazio, Stefano
    Cittone, Micol
    Minisini, Rosalba
    Magnani, Corrado
    Pirisi, Mario
    HEPATOLOGY, 2019, 70 : 803A - 804A
  • [36] Abbreviated pharmacokinetic profiles in area-under-the-curve monitoring of cyclosporine therapy in de novo renal transplant patients treated with Sandimmune or Neoral
    Marsh, CL
    THERAPEUTIC DRUG MONITORING, 1999, 21 (01) : 27 - 34
  • [37] Cyclosporine peak levels provide a better correlation with the area-under-the-curve than trough levels in liver transplant patients treated with neoral
    Cantarovich, M
    Barkun, J
    Besner, JG
    Metrakos, P
    Alpert, E
    Deschénes, M
    Aalamian, Z
    Tchervenkov, JI
    TRANSPLANTATION PROCEEDINGS, 1998, 30 (04) : 1462 - 1463
  • [38] Ursodeoxycholic acid improves liver function via phenylalanine/tyrosine pathway and microbiome remodelling in patients with liver dysfunction (vol 8, 11874, 2018)
    Kim, Da Jung
    Yoon, Seonghae
    Ji, Sang Chun
    Yang, Jinho
    Kim, Yoon-Keun
    Lee, SeungHwan
    Yu, Kyung-Sang
    Jang, In-Jin
    Chung, Jae-Yong
    Cho, Joo-Youn
    SCIENTIFIC REPORTS, 2019, 9 (1)
  • [39] DIETARY FISH OIL IMPROVES RENAL RESERVE FILTRATION CAPACITY (RRFC) AFTER AMINO-ACID INFUSION IN CYCLOSPORINE-TREATED RENAL-TRANSPLANT PATIENTS
    VANDERHEIDE, JJH
    BILO, HJG
    SLUITER, WJ
    DONKER, AJM
    TEGZESS, AM
    KIDNEY INTERNATIONAL, 1990, 37 (01) : 614 - 614
  • [40] The influence of Saint John's wort extract on blood concentrations of cyclosporin A, tacrolimus and mycophenolic acid in renal transplant patients
    Bauer, S
    Mai, I
    Johne, A
    Stormer, E
    Budde, K
    Roots, I
    THERAPEUTIC DRUG MONITORING, 2003, 25 (04) : 511 - 511